Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

After tumor removal, the woman regained normal hormone levels, menstruated, and had a healthy baby.

Finasteride may affect male fertility by interfering with specific sperm signaling.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Vitamin D levels do not significantly relate to the causes of PCOS or DOR in infertile patients.

Finasteride may cause infertility in rats by affecting epididymis and sperm function.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

PCOS is a major cause of infertility and requires personalized treatment.

Recombinant gonadotropins improve future fertility in CHH patients.

FUE is a less invasive hair transplant method suitable for many patients, but it has limitations and may not replace traditional techniques.

Some common medications can harm male fertility, but many effects can be reversed.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Combining FUT and FUE techniques improves hair transplant results for severe baldness in Asians.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

PCOS-related infertility is managed with lifestyle changes and medications.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.